Skip to main content

Table 1 Demographic and clinical features of the subjects in the study

From: The association between oxidized low-density lipoprotein antibodies and hematological diseases

Group

Gender (M/F)

Age

BMI

SBP*

DBP+

cases with non lymphatic leukemia

49/49

43.2 ± 18.18

23.2 ± 3.36

126.0 ± 16.33

68.9 ± 12.05

cases with lymphatic leukemia

25/35

31.1 ± 15.40

23.0 ± 3.60

123.1 ± 9.30

79.3 ± 6.2

cases with Hemolytic anemia

30/22

50.5 ± 20.40

23.7 ± 3.99

133.8 ± 19.62

66.1 ± 10.04

cases with immunothrombocytopenia

25/41

43.7 ± 17.37

22.5 ± 3.11

123.7 ± 13.54

76.9 ± 9.99

cases with multiple myeloma

32/25

57.3 ± 8.49

24.9 ± 2.73

135.0 ± 13.28

81.3 ± 12.24

cases with non Kochkin’s

22/36

48.4 ± 12.45

26.6 ± 4.36

109.7 ± 11.49

73.6 ± 8.97

cases with myelodysplastic syndrome

25/30

61.9 ± 13.57

25.1 ± 3.67

122.2 ± 13.10

67.7 ± 10.15

patients with primary hypertension

47/43

56.5 ± 10.87

25.8 ± 3.49

159.2 ± 17.15

94.2 ± 11.03

healthy normal persons+

40/50

45.4 ± 11.67

24.5 ± 3.35

115.3 ± 16.31

78.2 ± 10.03

F/x 2

10.724

16.662

4.766

40.045

30.959

P

0.218

<0.001

0.02

<0.001

<0.001

  1. *: SBP systoilic blood pressure, +: DBP diastolic blood pressure